MedTrace Logo

Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy

NCT06947889 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2025-04-27

No results posted yet for this study

Summary

The AID2GAIT project aims to develop a biofeedback system with the aim of improving the outcomes of robot-assisted gait training (RAGT) in pediatric patients with cerebral palsy. The physiological signals of children during RAGT therapy sessions, acquired through non-invasive technologies, will be analyzed. These technologies specifically are:

* wearable technology (smartwatch), from which the HRV (Heart Rate Variability) signal will be measured;
* infrared thermography, from which the temperature in salient facial regions will be obtained;
* fNIRS (functional near-infrared spectroscopy), from which information on brain activity and its changes over time will be obtained.

Information on the kinematics of the exoskeleton used during RAGT will be extracted.

The RAGT will be performed using the Lokomat orthosis (Hocoma), the most widely used exoskeleton in rehabilitation that facilitates a bilaterally symmetrical gait, as the individual actively tries to advance each limb during walking, combined with a patented dynamic body weight support system.

Conditions

  • Cerebral Palsy Infantile
  • Robotic Assisted Gait Training

Interventions

OTHER

RAGT

Biofeedback based system development to enhance Robotic Assisted Gait Training in cerebral palsy pediatric patients

Sponsors & Collaborators

  • Fondazione Centri di Riabilitazione Padre Pio Onlus - Gli Angeli di Padre Pio

    collaborator UNKNOWN

  • G. d'Annunzio University

    lead OTHER

Principal Investigators

  • Daniela Cardone, Dr · G. d'Annunzio University

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-03-31
Completion
2026-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06947889 on ClinicalTrials.gov